RXO (NYSE: RXO) reported Q3 EPS of $0.01, $0.24 worse than the analyst estimate of $0.25. Revenue for the quarter came in at $1.42 billion.

Fourth-Quarter Outlook

RXO expects fourth-quarter 2025 adjusted EBITDA to be between $20 million and $30 million.

For earnings history and earnings-related data on RXO (RXO) click here.